Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBED9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLEKHM3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | AMT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NAGK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | STK38L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GAB2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IFT81 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CCDC80 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | MEF2B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DIS3L2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |